The retinoblastoma tumour suppressor in development and cancer
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The role of RB in promoting cellular differentiation during embryonic development and in adult lineages has been well characterized in mutant mice and in vitro systems20,42,58–61.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [61]
In the citing paper
“The growth suppressive properties of Rb are largely, but not completely, associated with its binding to the transcription factor E2F and repressing transcription at target promoters (Classon and Harlow, 2002; Harbour and Dean, 2000; Stevaux and Dyson, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
In the citing paper
“In virtually all human cancer cells, this circuit is dysregulated by either overexpression of cyclin D1, loss of p16Ink4a, the mutation of CDK4 to an Ink4-refractory state, or the loss of Rb itself (Classon and Harlow, 2002).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Classon and Harlow, 2002
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 1×
“RB is therefore linked directly to the intricate regulatory network that controls cell-cycle progressio”
BackgroundA human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459 · cited 1×
“These findings indicated that RB is a regulator of cell proliferatio”
BackgroundHuman Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Self-citationMice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Research works printed but not linked: 4
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. W. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Guo, Z., Yikang, S., Yoshida, H., Mak, T. & Zacksenhaus, E. Inactivation of the retinoblastoma tumor suppressor induces Apaf-1 dependent and independent apoptotic pathways during embryogenesis. Cancer Res. 61, 8395–8400 (2001).
- Vooijs, M. & Berns, A. Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293–5303 (1999). · DOI
- Elliott, M. J., Dong, Y. B., Yang, H. & McMasters, K. M. E2F-1 upregulates c-Myc and p14ARF and induces apoptosis in colon cancer cells. Clin. Cancer Res. 7, 3590–3597 (2001).
Cited by
Items 101–200 of 738
Cell cycle progression in response to oxygen levels
Ortmann, B., Druker, J., & Rocha, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1645-9 · Cited by 123
“Loss of function of RB leads to deregulated cell proliferation and promotes tumour progression [40].”
BackgroundGains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma
Grasemann, C., Kappler‐Gratias, S., Stephan, H., Schüler, A., Schramm, A. R., Klein‐Hitpaß, L., Rieder, H., Schneider, S., Kappes, F., Eggert, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208792 · Cited by 125
“However, additional roles have emerged (Classon and Harlow, 2002; Mittnacht, 2005).”
BackgroundChen, P.-L., Liu, F., Cai, S., Lin, X., Li, A., Chen, Y., Gu, B., Lee, E. Y.-H. P., & Lee, W.-H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3535-3542.2005 · Cited by 125
“phosphorylation by cyclin D/CDK4/6 and cyclin E/CDK2 complexes at G1/S transition (4); however, why the presence of those kinases capable of hyperphosphorylation of RB is not sufficient for cells to enter S phase when CtIP is depleted is not known.”
BackgroundLee, M.-N., Tseng, R.-C., Hsu, H.-S., Chen, J.-Y., Tzao, C., Ho, W. L., & Wang, Y.-C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2694 · Cited by 124
RB, the conductor that orchestrates life, death and differentiation
Khidr, L., & Chen, P.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209612 · Cited by 123
“Taken together, these studies suggested that Rb / cells must escape apoptosis in the development of retinoblastoma (Classon and Harlow, 2002).”
BackgroundPituitary Hypoplasia in Pttg−/−Mice Is Protective for Rb+/−Pituitary Tumorigenesis
Chesnokova, V., Kovacs, K., Castro, A.-V., Zonis, S., & Melmed, S. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0137 · Cited by 122
“Mice bearing a single Rb mutant allele develop pituitary tumors with almost complete penetrance (6-8).”
BackgroundMethodIdentification of Target Genes of the p16INK4A-pRB-E2F Pathway
Vernell, R., Helin, K., & Müller, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304930200 · Cited by 123
Longworth, M. S., Herr, A., Ji, J.-Y., & Dyson, N. J. (2008) · Genes & Development · doi:10.1101/gad.1631508 · Cited by 122
“Mice carrying mutant alleles of Rb, p107, and p130 have complex phenotypes that are not fully understood, but include changes in both E2F-dependent and E2F-independent functions (Classon and Harlow 2002).”
BackgroundFilipczyk, A. A., Laslett, A. L., Mummery, C. L., & Pera, M. F. (2007) · Stem Cell Research · doi:10.1016/j.scr.2007.09.002 · Cited by 125
“All rights reserved doi:10.1016/j.scr.2007.09.002 Classon and Harlow, 2002), which is the essential switch driving, for example, an undifferentiated myoblast toward the functional myotube.”
BackgroundInfluentialLysine methylation regulates the pRb tumour suppressor protein
Munro, S., Khaire, N., Inche, A. G., Carr, S. M., & Thangue, N. B. L. (2010) · Oncogene · doi:10.1038/onc.2009.511 · Cited by 133
Roles and mechanisms of cellular senescence in regulation of tissue homeostasis
Ohtani, N., & Hara, E. (2013) · Cancer Science · doi:10.1111/cas.12118 · Cited by 119
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage
Inoue, Y., Kitagawa, M., & Taya, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601652 · Cited by 141
“The retinoblastoma tumor suppressor protein (pRB) is a negative regulator of cell proliferation (Classon and Harlow, 2002).”
BackgroundPotential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma
Miyashita, K., Kawakami, K., Nakada, M., Mai, W., Shakoori, A., Fujisawa, H., Hayashi, Y., Hamada, J., & Minamoto, T. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0760 · Cited by 132
Cell cycle inhibitors in normal and tumor stem cells.
Cheng, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207945 · Cited by 117
“In somatic cells, movement through G1 and into the S phase is driven by the active form of the Cyclin D1, 2,3/CDK4, 6 complex and the subsequent phosphorylation retinoblastoma (Rb) protein (Classon and Harlow, 2002).”
BackgroundThe RB-E2F1 Pathway Regulates Autophagy
Jiang, H., Martin, V., Gomez-Manzano, C., Johnson, D. G., Alonso, M., White, E., Xu, J., McDonnell, T. J., Shinojima, N., & Fueyo, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1604 · Cited by 115
“Copyright © 2010 American Association for Cancer Research hypophosphorylation of RB, which is the active form of the protein (6).”
BackgroundInfluentialThe CDK Network: Linking Cycles of Cell Division and Gene Expression
Fisher, R. P. (2012) · Genes & Cancer · doi:10.1177/1947601912473308 · Cited by 128
CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
Zhang, Z., Zhang, Y., Gao, F., Han, S., Cheah, K. S., Tse, H.-F., & Lian, Q. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.09.009 · Cited by 114
“Rb1 is known to initiate retinoblastoma in humans.(39) RB1 null human ESCs generated by CRISPR/Cas9 showed aberrant mitochondria and were shown by drug screening to be sensitive to”
BackgroundZhang, Y.-X., Sicinska, E., Czaplinski, J. T., Remillard, S. P., Moss, S., Wang, Y., Brain, C., Loo, A., Snyder, E. L., Demetri, G. D., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0387 · Cited by 114
Cellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 114
Carr, S. M., Munro, S., Kessler, B. M., Oppermann, U. C. T., & Thangue, N. B. L. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.311 · Cited by 123
“pRb regulates different cell fates, including cell cycle arrest, apoptosis, differentiation and senescence (Classon and Harlow, 2002; Giacinti and Giordano, 2006; van den Heuvel and Dyson, 2008).”
BackgroundPilkinton, M. A., Sandoval, R., & Colamonici, O. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210562 · Cited by 132
Lung Cancer: Are we up to the Challenge?
Esposito, L., Conti, D., Ailavajhala, R., Khalil, N., & Giordano, A. (2010) · Current Genomics · doi:10.2174/138920210793175903 · Cited by 115
“What is known is that the tumor suppressor RB1 is inactivated in a broad range of human tumors [36, 37], including pediatric retinoblastomas and about 90% of human SCLC.”
BackgroundIdentification of genes associated with tumorigenesis of retinoblastoma by microarray analysis
Chakraborty, S., Khare, S., Dorairaj, S. K., Prabhakaran, V. C., Prakash, D. R., & Kumar, A. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.002 · Cited by 113
Growth suppression and radiosensitivity increase by HMGB1 in breast cancer
Jiao, Y., Wang, H., & Fan, S. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00669.x · Cited by 106
Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt
Zhang, J., Xu, K. L., Liu, P., Geng, Y., Wang, B., Gan, W., Guo, J., Wu, F., Chin, Y. R., Berrios, C. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.04.023 · Cited by 116
“This domain is poorly conserved between the three pocket proteins, explaining our observation that Sin1 interacted with Rb, but not the other two Rb-related pocket proteins, p107 and p130 (Classon and Harlow, 2002; Dick and Rubin, 2013; Figure 2L).”
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P., Wolvetang, E., Ghysdael, J., Rowe, M., & Hara, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302085 · Cited by 104
“Unlike other DNA tumor virus oncoproteins, which possess immortalizing activity, such as human papillomavirus E7 or adenovirus E1A (Jansen-Durr, 1996; Classon and Harlow, 2002), LMP does not bind to the pRB family proteins.”
BackgroundOvca1 regulates cell proliferation, embryonic development, and tumorigenesis
Chen, C., & Behringer, R. R. (2004) · Genes & Development · doi:10.1101/gad.1162204 · Cited by 119
“We further examined the phosphorylation status of retinoblastoma (RB) in MEFs because of its known role in regulating cell cycle progression (Classon and Harlow 2002).”
BackgroundAn overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein
Hirschi, A., Cecchini, M., Steinhardt, R. C., Schamber, M. R., Dick, F. A., & Rubin, S. M. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1868 · Cited by 102
“The importance of phosphorylation for regulating Rb activity as a tumor suppressor is underscored by the fact that genes encoding cyclin D and p16 are frequently mutated in cancers, leading to constitutive Rb hyperphosphorylatio”
BackgroundTumor Suppressors Having Oncogenic Functions: The Double Agents
Datta, N., Chakraborty, S., Basu, M., & Ghosh, M. K. (2020) · Cells · doi:10.3390/cells10010046 · Cited by 125
“It is a cell cycle regulator, restricting normal cells in the G1 phase; however, its function is often inactivated in cancers [14].”
BackgroundCell Size Checkpoint Control by the Retinoblastoma Tumor Suppressor Pathway
Fang, S., Reyes, C. D. L., & Umen, J. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0020167 · Cited by 106
“extracellular growth factor signals [15,23].”
BackgroundPhosphorylation Controls Ikaros's Ability To Negatively Regulate the G1-S Transition
Arco, P. G.-D., Maki, K., & Georgopoulos, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2797-2807.2004 · Cited by 102
Liver-Specific pRB Loss Results in Ectopic Cell Cycle Entry and Aberrant Ploidy
Mayhew, C. N., Bosco, E. E., Fox, S. R., Okaya, T., Tarapore, P., Schwemberger, S. J., Babcock, G. F., Lentsch, A. B., Fukasawa, K., & Knudsen, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4221 · Cited by 101
“The retinoblastoma tumor suppressor (Rb) plays a critical role in cellular proliferation control and inhibition of oncogenic transformation (1, 2).”
BackgroundLedl, A., Schmidt, D., & Müller, S. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208539 · Cited by 112
“The tumor suppressor function of pRB depends on the integrity of the pocket domain (Classon and Harlow, 2002).”
BackgroundLSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression
Liang, Y., Ahmed, M., Guo, H., Soares, F., Hua, J. T., Gao, S., Lu, C., Poon, C., Han, W., Langstein, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0496 · Cited by 101
“Tumor suppressor retinoblastoma-associated protein 1 (RB1) is often lost in PCa (38-40), and has recently been reported to repress transcription in presence of androgen in PCa (41).”
BackgroundWu, M.-Y., Tsai, T.-F., & Beaudet, A. L. (2006) · Genes & Development · doi:10.1101/gad.1452206 · Cited by 100
“This result led to studies demonstrating that Rbbp1/Arid4a, Rbbp1l1/Arid4b, and Rb play a role in the regulation of the PWS/AS imprinted domain, representing a novel epigenetic mechanism of regulation of genomic imprinting.”
BackgroundInfluentialGuarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway
Chakraborty, A., Uechi, T., & Kenmochi, N. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.73 · Cited by 111
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
“…transcription factors, which transactivate genes encoding cell cycle proteins and DNA replication factors required for cell growth (Bracken et al., 2004; Blais and Dynlacht, 2007). pRb is a member of the pocket protein family along with the related proteins p107 and p130 (Classon and Harlow, 2002).”
Grewal, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.12.005 · Cited by 107
“Rb's role as a tumour suppressor has historically been considered in the context of this role as a cell cycle regulator [118].”
BackgroundKim, S., Tiedt, R., Loo, A., Horn, T., Delach, S., Kovats, S., Haas, K., Engstler, B. S., Cao, A., Pinzon-Ortiz, M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26215 · Cited by 93
“Equally important are genetic aberrations in signaling pathways upstream of D cyclins, such as RAS mutations ( KRAS and NRAS ), the BRAF V600E mutation, MEK mutation, PI3KCA mutation, and PTEN deletion, which then result in elevated levels of D cyclins with subsequent CDK4/6 activation [4, 5, 8].”
Johnson, J. L., Pillai, S., Pernazza, D., Sebti, S. M., Lawrence, N. J., & Chellappan, S. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2647 · Cited by 93
“Not surprisingly, oncogenic mutations target the Rb–E2F pathway to promote cell proliferation (5).”
BackgroundTumor suppressor p16 methylation in multiple myeloma: biological and clinical implications
Gonzalez-Paz, N., Chng, W. J., McClure, R. F., Blood, E., Oken, M. M., Ness, B. V., James, C. D., Kurtin, P. J., Henderson, K., Ahmann, G. J., et al. (2007) · Blood · doi:10.1182/blood-2006-05-024661 · Cited by 94
Ji, Y., & Studzinski, G. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3029 · Cited by 101
Zeng, X., & Rao, M. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.017 · Cited by 92
BMP-2 induces EMT and breast cancer stemness through Rb and CD44
Huang, P., Chen, A., He, W., Li, Z., Zhang, G., Liu, Z., Liu, G., Liu, X., He, S.-L., Xiao, G., et al. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.39 · Cited by 97
Zhu, Y., Gu, J., Li, Y., Peng, C., Shi, M., Wang, X., Wei, G., Ge, O., Wang, D., Zhang, B., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.044 · Cited by 91
“RBL2 canbindwith LXCXE-containingproteins involved in transcriptional repression [34,35].”
BackgroundMYC Modulation around the CDK2/p27/SKP2 Axis
Hydbring, P., Castell, A., & Larsson, L.-G. (2017) · Genes · doi:10.3390/genes8070174 · Cited by 90
The molecular biology of prostate cancer: current understanding and clinical implications
Gandhi, J., Afridi, A., Vatsia, S. K., Joshi, G. A., Joshi, G. S., Kaplan, S. A., Smith, N. L., & Khan, S. A. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-017-0023-8 · Cited by 106
“It encodes a nuclear transcription factor that regulates cell cycle at the G0/G1 phase [61].”
BackgroundBenevolenskaya, E. V. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-057 · Cited by 118
“Although pRB has a repressive action on the transcription factor E2F, pRB is also known to co-operate with transcription factors that regulate differentiation (Classon and Harlow 2002).”
BackgroundThe Emerging Role of Pituitary Tumor Transforming Gene in Tumorigenesis
Tfelt‐Hansen, J., Kanuparthi, D., & Chattopadhyay, N. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.2.130 · Cited by 92
E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9
Oberley, M. J., Inman, D. R., & Farnham, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307733200 · Cited by 90
Diversity within the pRb pathway: is there a code of conduct?
Munro, S., Carr, S. M., & Thangue, N. B. L. (2012) · Oncogene · doi:10.1038/onc.2011.603 · Cited by 105
“…kinase (Cdk) complexes causes the release of E2F-1 and the activation of genes required for the entry into S phase (Sherr, 2000; Classon and Harlow, 2002; Longworth and Dyson, 2010). pRb belongs to a family of proteins referred to as ‘pocket proteins’, which also includes the…”
BackgroundE2F transcription factors and digestive system malignancies: How much do we know?
Xanthoulis, A. I., & TINIAKOS, D. G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i21.3189 · Cited by 96
Chromatin regulation and non-coding RNAs at mammalian telomeres
Schoeftner, S., & Blasco, M. A. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.09.015 · Cited by 104
Sharma, A. M., Comstock, C. E. S., Knudsen, E. S., Cao, K. H., Hess-Wilson, J. K., Morey, L. M., Barrera, J. G., & Knudsen, K. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4424 · Cited by 87
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Regulation of transcription and chromatin structure by pRB: Here, there and everywhere
Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 88
“proteins to activate transcription of cell cycle genes.(1) Viral oncoproteins, like E1A, bind to pRB, preventing it from interacting with E2Fs and thereby inducing cell proliferation.”
BackgroundIdentification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes
Wu, M., Eldin, K. W., & Beaudet, A. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn253 · Cited by 95
Switching Cdk2 On or Off with Small Molecules to Reveal Requirements in Human Cell Proliferation
Merrick, K. A., Wohlbold, L., Zhang, C., Allen, J. J., Horiuchi, D., Huskey, N. E., Goga, A., Shokat, K. M., & Fisher, R. P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.031 · Cited by 91
“The deregulation of pocket protein function and its control by CDKs is a hallmark of many cancers (Classon and Harlow, 2002).”
miR-335 Directly Targets Rb1 (pRb/p105) in a Proximal Connection to p53-Dependent Stress Response
Scarola, M., Schoeftner, S., Schneider, C., & Benetti, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0141 · Cited by 96
A role for the transcription factor HEY1 in glioblastoma
Hulleman, E., Quarto, M., Vernell, R., Masserdotti, G., Colli, E., Kros, J. M., Levi, D., Gaetani, P., Tunici, P., Finocchiaro, G., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00307.x · Cited by 84
“The importance of the pRB/E2F signalling pathway in neural and glial differentiation is further underscored by the observation that alterations in the pRB/E2F pathway are found in several types of brain tumours, including gliomas of different grades [2, 33-35].”
BackgroundDick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79
“In general terms, pRB has an established role in mediating a G1 arrest in development and in response to many growth regulatory signals [5].”
BackgroundDiscovery and Evaluation of Dual CDK1 and CDK2 Inhibitors
Payton, M., Chung, G., Yakowec, P., Wong, A., Powers, D., Xiong, L., Zhang, N., Leal, J., Bush, T. L., Santora, V., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2507 · Cited by 83
Targeting Tumor Suppressor Networks for Cancer Therapeutics
Guo, X. E., Ngo, B., Modrek, A. S., & Lee, W. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095151 · Cited by 103
“RB is now known as a universal cell cycle regulator with a central role in governing the passage of cells through the G1 phase, and particularly, the restriction point (R point), control of which is lost in most cancer cells (19).”
BackgroundHassler, M., Singh, S., Yue, W. W., Luczynski, M. T., Lakbir, R., Sánchez‐Sánchez, F., Bader, T., Pearl, L. H., & Mittnacht, S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.023 · Cited by 84
“Some tumor viruses inhibit Rb, and mutations in the Rb gene are associated with oncogenic transformation (Classon and Harlow, 2002).”
Siddiqui, H., Solomon, D. A., Gunawardena, R. W., Wang, Y., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7719-7731.2003 · Cited by 78
“The retinoblastoma tumor suppressor, RB, functions as a negative regulator of cell cycle progression that is frequently inactivated in human cancers (10, 22, 75).”
BackgroundThe relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Bower, J. J., Vance, L. D., Psioda, M., Smith-Roe, S. L., Simpson, D. A., Ibrahim, J. G., Hoadley, K. A., Perou, C. M., & Kaufmann, W. K. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0009-7 · Cited by 76
Cell cycle, proteolysis and cancer
Yamasaki, L., & Pagano, M. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.08.005 · Cited by 83
“In fact, 50% of human tumors contain loss-of-function mutations in RB [2,6].”
BackgroundKooi, I. E., Mol, B. M., Massink, M. P. G., de Jong, M. C., de Graaf, P., van der Valk, P., Meijers-Heijboer, H. E. J., Kaspers, G. J. L., Moll, A. C., Riele, H. T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153323 · Cited by 81
“Since p130 is primarily expressed in G0-cells restricting them for cell cycle entry [39], loss of p130 could prevent cellular senescence and promote the benign-tomalignant transition.”
BackgroundAutophagy regulation in cancer development and therapy.
White, E. J., Martín, V., Liu, J.-L., Klein, S. R., Piya, S., Gomez‐Manzano, C., Fueyo-Margareto, J., & Jiang, H. (2011) · American Journal of Cancer Research · Cited by 85
Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator
Zhu, L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.009 · Cited by 92
“An important component in Rb studies was the identification of the two Rb related proteins p107 and p130, which are more closely related to each other than either one is to Rb [8,9].”
BackgroundWen, H., Andrejka, L., Ashton, J., Karess, R. E., & Lipsick, J. S. (2008) · Genes & Development · doi:10.1101/gad.1626308 · Cited by 85
Sdek, P., Ying, H., Zheng, H., Margulis, A., Tang, X., Tian, K., & Xiao, Z.-X. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406062200 · Cited by 74
siRNA-mediated gene silencing: a global genome view
Semizarov, D., Kroeger, P., & Fesik, S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh714 · Cited by 79
“It is known that Rb1 can regulate transcription through chromatic modification mechanisms by forming complexes with HDACs [reviewed in (11,34)].”
BackgroundRetinoblastoma: present scenario and future challenges
Byroju, V. V., Nadukkandy, A. S., Cordani, M., & Kumar, L. D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01223-z · Cited by 106
“The major signaling pathways involved in retinoblastoma initiation and development are Rb, p53, Ras/MAPK and Notch pathways [18, 19].”
Jayasurya, R., Sathyan, K. M., Lakshminarayanan, K., Abraham, T., Nalinakumari, K. R., Abraham, E. K., Nair, M. K., & Kannan, S. (2005) · Modern Pathology · doi:10.1038/modpathol.3800387 · Cited by 80
Wikman, H., & Kettunen, E. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.4.515 · Cited by 72
Haigis, K., Sage, J., Glickman, J., Shafer, S., & Jacks, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509053200 · Cited by 72
Telomerase expression in lung preneoplasia and neoplasia
Lantuéjoul, S., Salon, C., Soria, J., & Brambilla, E. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22473 · Cited by 84
“P21 inhibits cyclin-dependent kinases, prevents phosphorylation and inactivation of Rb and related proteins P107 and P130.(11) P14 binds human double minute protein 2 (HDM2) and thus inhibits P53 degradation triggered by HDM2.”
BackgroundCell-intrinsic regulators of proliferation in vertebrate retinal progenitors
Levine, E. M., & Green, E. S. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.09.001 · Cited by 82
Immortalized keratinocyte lines derived from human embryonic stem cells
Iuchi, S., Dabelsteen, S., Easley, K., Rheinwald, J. G., & Green, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510953103 · Cited by 77
Cerezo, A., Guadamillas, M. C., Goetz, J. G., Sánchez-Perales, S., Klein, E., Assoian, R. K., & del Pozo, M. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00315-09 · Cited by 71
“During G1, activated cyclin D-cdk4/6 and cyclin E-cdk2 phosphorylate retinoblastoma protein (pRb) and the other pocket family proteins, p130 (Rb2) and p107 (7, 50).”
BackgroundModulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Seville, L., Shah, N., Westwell, A. D., & Chan, W. C. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053765816 · Cited by 81
Goh, X. Y., Rees, J. R. E., Paterson, A., Chin, S., Marioni, J. C., Save, V., O’Donovan, M., Eijk, P. P., Alderson, D., Ylstra, B., et al. (2011) · Gut · doi:10.1136/gut.2010.234179 · Cited by 76
“The identification of regions of genomic gains and losses has resulted in the discovery of novel oncogenes(4) and tumour suppressor genes (TSGs), respectively.(5) Similar to other cancers, common high level-amplifications ($25% of cases) have been frequently reported in OAC.”
BackgroundAusoni, S., Boscolo‐Rizzo, P., Singh, B., Mosto, M. C. D., Spinato, G., Tirelli, G., Spinato, R., & Azzarello, G. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9625-1 · Cited by 73
“overexpression of p16-INK4A, and cell G1-S phase transition [57].”
BackgroundTargeted Protein Degradation Induced by HEMTACs Based on HSP90
Li, Z., Ma, S., Zhang, L., Zhang, S., Ma, Z., Du, L., & Li, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01648 · Cited by 74
Chung, K., Cho, S., Shin, J., Kim, D.-H., Choi, J., Choi, S. Y., Rhee, Y. K., Hong, H., & Lee, K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs341 · Cited by 70
MacDonald, J. I., & Dick, F. A. (2012) · Genes & Cancer · doi:10.1177/1947601912473305 · Cited by 80
Markers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
Wierstra, I., & Alves, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.119 · Cited by 68
“…of E2F (Adams and Kaelin, 1995; Weinberg, 1995; Ezhevsky et al., 1997; Dyson, 1998; Lundberg and Weinberg, 1998; Harbour et al., 1999; Sherr and Roberts, 1999; Harbour and Dean, 2000; Zhang et al., 2000; Adams, 2001; Sherr, 2001; Classon and Harlow, 2002; Sherr and McCormick, 2002; Cobrinik, 2005).”
BackgroundNakajima, H., Nakajima, H. O., Tsai, S.-C., & Field, L. J. (2004) · Circulation Research · doi:10.1161/01.res.0000132279.99249.f4 · Cited by 67
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 73
Alonso, M. M., Fueyo-Margareto, J., Shay, J. W., Aldape, K., Jiang, H., Lee, O.-H., Johnson, D. G., Xu, J., Kondo, Y., Kanzawa, T., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji340 · Cited by 66
BRAF as a melanoma susceptibility candidate gene?
Laud, K., Kannengiesser, C., Avril, M., Chompret, A., Stoppa‐Lyonnet, D., Desjardins, L., Eychène, A., Démenais, F., Lenoir, G., & Paillerets, B. B. (2003) · PubMed · Cited by 75
Klausen, P. H., Bjerregaard, M. D., Borregaard, N., & Cowland, J. B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003474 · Cited by 76
“In agreement with our data, p107 has been shown to be regulated at the transcriptional level and to accumulate only at the stage of differentiation where the cell progresses through the cell cycle [41, 42].”
BackgroundPost-translational modifications on the retinoblastoma protein
Zhou, L., Ng, D. S., Yam, J. C. S., Chen, L. J., Tham, C. C. Y., Pang, C. P., & Chu, W. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00818-x · Cited by 71
“pRb, together with its homologs p107 and p130, belongs to the “pocket protein” family and was first identified to serve as a cell cycle regulator to exert its tumour suppressive effects [12, 13].”
BackgroundmiR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas
Shi, L., Jiang, D., Sun, G., Wan, Y., Zhang, S., Zeng, Y., Pan, T., & Wang, Z. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0951-z · Cited by 63
“In mammals, the family of retinoblastoma (Rb) proteins is a major tumor suppressor pathway consisting of Rb1, Rbl1, and Rbl2 [17].”
BackgroundJiao, W., Datta, J., Lin, H., Dundr, M., & Rane, S. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605271200 · Cited by 67
Lu, J., Ruhf, M.-L., Perrimon, N., & Leder, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610279104 · Cited by 73
Caruso, J. A., Duong, M. T., Carey, J. P. W., Hunt, K. K., & Keyomarsi, K. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1235 · Cited by 69
“The cyclin E–CDK2 complex further phosphorylates pRb, enhancing the E2F-mediated upregulation of S-phase–specific genes (8).”
Metadata
- Authors
- Classon, M., & Harlow, E.
- Affiliations
- Harvard University (US)
- ORCID
- Classon, Marie
- Venue
- Nature Reviews Cancer
- Published
- 2002-12-01
- Volume
- 2
- Issue
- 12
- Pages
- 910-917
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1998492363
- Cited by
- 738
- References
- 133
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 20 · 2021: 18 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 28 · 2016: 24 · 2015: 32 · 2014: 35 · 2013: 23 · 2012: 42
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma protein, RB1, tumour suppressor, cell proliferation, cell differentiation, cell survival, Rb family proteins, protein redundancy, knockout mice, development (biology), cancer
- MeSH terms
- Animals, Cell Division, Humans, Nuclear Proteins, Phenotype, Phosphoproteins, Proteins, Retinoblastoma, Signal Transduction, Retinoblastoma Protein, Genes, Retinoblastoma, Mice, Knockout, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.